Patents by Inventor Wilfred Wayne Lautt

Wilfred Wayne Lautt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF S-ADENOSYLMETHIONINE, VITAMIN E, AND VITAMIN C FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DYSFUNCTION
    Publication number: 20140187509
    Abstract: The present invention provides a method of preventing or treating cardiovascular dysfunction by administering a therapeutically effective amount of (a) one or more of (i) S-adenosylmethionine or a derivative or pharmaceutically acceptable salt thereof and (ii) N-acetylcysteine or a derivative or pharmaceutically acceptable salt thereof; (b) vitamin E or a derivative or pharmaceutically acceptable salt thereof; and (c) vitamin C or a derivative or pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: April 13, 2012
    Publication date: July 3, 2014
    Applicant: SCIMAR LTD.
    Inventors: Wilfred Wayne Lautt, Zhi Ming
  • Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury
    Patent number: 8716260
    Abstract: The present invention provides antioxidant compositions comprising S-adenosylmethionine (SAMe), vitamin E and vitamin C and uses thereof for the treatment of liver injury and insulin resistance.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: May 6, 2014
    Assignee: University of Manitoba
    Inventors: Wilfred Wayne Lautt, Zhi Ming
  • Use of drug combinations for treating insulin resistance
    Patent number: 8673964
    Abstract: The present invention provides pharmaceutical compositions comprising: (a) a modulator of hepatic parasympathetic tone, (b) at least one diabetes drug, and (c) a pharmaceutically acceptable carrier. The present invention includes methods for the treatment and/or prevention of insulin resistance, type 2 diabetes, impaired glucose intolerance, and other associated disorders with pharmaceutical compositions described herein. The invention also provides for a kit comprising a pharmaceutical composition and instructions for its use.
    Type: Grant
    Filed: May 20, 2005
    Date of Patent: March 18, 2014
    Assignee: DiaMedica Inc.
    Inventor: Wilfred Wayne Lautt
  • Use of S-adenosylmethionine, vitamin E, and vitamin C for the treatment of oxidative liver injury and insulin resistance
    Patent number: 8063024
    Abstract: The present invention provides antioxidant compositions comprising S-adenosylmethionine (SAMe), vitamin E and vitamin C and uses thereof for the treatment of liver injury and insulin resistance.
    Type: Grant
    Filed: January 26, 2006
    Date of Patent: November 22, 2011
    Assignee: University of Manitoba
    Inventors: Wilfred Wayne Lautt, Zhi Ming
  • USE OF S-ADENOSYLMETHIONINE, VITAMIN E, AND VITAMIN C FOR THE TREATMENT OF OXIDATIVE LIVER INJURY OR INSULIN RESISTANCE
    Publication number: 20110230434
    Abstract: The present invention provides antioxidant compositions comprising S-adenosylmethionine (SAMe), vitamin E and vitamin C and uses thereof for the treatment of liver injury and insulin resistance.
    Type: Application
    Filed: May 27, 2011
    Publication date: September 22, 2011
    Applicant: University of Manitoba
    Inventors: Wilfred Wayne Lautt, Zhi Ming
  • Treatment of insulin resistance by modulating somatostatin using somatostatin receptor antagonists
    Patent number: 8017575
    Abstract: The present invention provides the use of somatostatin antagonists for treating and preventing HISS-dependent insulin resistance and hemorrhage induced insulin resistance. The present further provides pharmaceutical compositions comprising a somatostatin antagonist and a pharmaceutically acceptable liver targeting compound.
    Type: Grant
    Filed: December 15, 2005
    Date of Patent: September 13, 2011
    Inventor: Wilfred Wayne Lautt
  • TREATMENT OF INSULIN RESISTANCE BY MODULATING SOMATOSTATIN USING SOMATOSTATIN RECEPTOR ANTAGONISTS
    Publication number: 20090270311
    Abstract: The present invention provides the use of somatostatin antagonists for treating and preventing HISS-dependent insulin resistance and hemorrhage induced insulin resistance. The present further provides pharmaceutical compositions comprising a somatostatin antagonist and a pharmaceutically acceptable liver targeting compound.
    Type: Application
    Filed: December 15, 2005
    Publication date: October 29, 2009
    Applicant: UNIVERSITY OF MANITOBA
    Inventor: Wilfred Wayne Lautt
  • Use of drug combinations for treating insulin resistance
    Publication number: 20090233995
    Abstract: The present invention provides pharmaceutical compositions comprising: (a) a modulator of hepatic parasympathetic tone, (b) at least one diabetes drug, and (c) a pharmaceutically acceptable carrier. The present invention includes methods for the treatment and/or prevention of insulin resistance, type 2 diabetes, impaired glucose intolerance, and other associated disorders with pharmaceutical compositions described herein. The invention also provides for a kit comprising a pharmaceutical composition and instructions for its use.
    Type: Application
    Filed: May 20, 2005
    Publication date: September 17, 2009
    Applicant: DiaMedica Inc.
    Inventor: Wilfred Wayne Lautt
  • Use of S-Adenosylmethionine, Vitamin E, and Vitamin C for the Treatment of Oxidative Liver Injury or Insulin Resistance
    Publication number: 20080262002
    Abstract: The present invention provides antioxidant compositions comprising S-adenosylmethionine (SAMe), vitamin E and vitamin C and uses thereof for the treatment of liver injury and insulin resistance.
    Type: Application
    Filed: January 26, 2006
    Publication date: October 23, 2008
    Applicant: UNIVERSITY OF MANITOBA
    Inventors: Wilfred Wayne Lautt, Zhi Ming
  • Method for treating insulin resistance through hepatic nitric oxide
    Publication number: 20040151785
    Abstract: There is provided a method of increasing insulin sensitivity by administering an effective amount of a compound which stimulates nitric oxide production in the liver. Also provided is a pharmaceutical composition having an effective amount of a compound which stimulates nitric oxide production in the liver and a pharmaceutically acceptable carrier.
    Type: Application
    Filed: January 21, 2004
    Publication date: August 5, 2004
    Applicant: DiaMedica Inc.
    Inventor: Wilfred Wayne Lautt
  • Use of cholinesterase antagonists to treat insulin resistance
    Publication number: 20030235609
    Abstract: There is provided a method of reducing insulin resistance in a mammalian subject comprising administering a suitable acetylcholine esterase antagonist
    Type: Application
    Filed: January 24, 2003
    Publication date: December 25, 2003
    Inventor: Wilfred Wayne Lautt
  • Use of phosphodiesterase antagonists to treat insulin resistance
    Publication number: 20030181461
    Abstract: A phosphodiesterase antagonist is used to reduce insulin resistance, and to amplify the effect of nitric oxide on skeletal muscle insulin-mediated glucose uptake in a mammal. In some instances, the antagonist is targeted to the liver. In some instances, the insulin resistance is hepatic insulin sensitizing substance (“HISS”) dependant insulin resistance.
    Type: Application
    Filed: January 24, 2003
    Publication date: September 25, 2003
    Inventors: Wilfred Wayne Lautt, Paula Macedo
  • Method for stimulating liver regeneration
    Publication number: 20020006930
    Abstract: There is provided an NO donor for use in regenerating the liver. Also provided is a pharmaceutical for liver regeneration including an effective amount of the chemical which promotes liver regeneration and a pharmaceutically acceptable carrier. Also provided is a method of stimulating liver regeneration by administering an effective amount of an NO donor or a chemical which stimulates cGMP production.
    Type: Application
    Filed: June 22, 2001
    Publication date: January 17, 2002
    Inventor: Wilfred Wayne Lautt